Evidence map›Paper›PMID 39251468›Full record

ArticleEndocrine2025

Typing diagnostic value of

Rui Zuo, Shuang Liu, Xinyi Ren, Wenbo Li, Zhu Xia, Lu Xu, Hua Pang

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. AVS-referenced diagnostic performance ofFrontiers in endocrinology · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Real world experience with [Frontiers in endocrinology · 2026
    Article
  7. Review
  8. Is CXCR4-targetedEJNMMI research · 2025
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rui ZuoDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Shuang LiuDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Xinyi RenDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Wenbo LiDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Zhu XiaDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.
Lu XuDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. lunaxuxu@foxmail.com.
Hua PangDepartment of Nuclear Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China. Phua1973@163.com.

Funding

Chongqing Medical University 0301020499QC-W0117
6 · The paper itself

Abstract

purposeOur goal was to compare the lateralization of

methodsWe retrospectively enrolled 61 patients with PA and all patients showed unilateral nodular lesions on CT and underwent

resultsThe study included 42 unilateral PA (UPA) and 19 bilateral PA (BPA). The area under curve (AUC) of

conclusions

Indexed as

HyperaldosteronismPositron Emission Tomography Computed TomographyAdrenal GlandsAdultAgedCoordination ComplexesFemaleHumansMaleMiddle AgedPeptides, CyclicReceptors, CXCR4Retrospective StudiesSensitivity and Specificity68Ga-pentixaforCoordination ComplexesCXCR4 protein, humanPeptides, CyclicReceptors, CXCR468Ga-pentixaforAdrenal vein samplingPET/CTPrimary aldosteronism

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.